Plasma PLP: the active coenzyme form of vitamin B6
Vitamin B6 (plasma) is the amount of vitamin B6 circulating in your blood. Vitamin B6 is a water-soluble nutrient you get from food and supplements. After absorption in the small intestine, the liver converts it into its active coenzyme forms, mainly pyridoxal 5′-phosphate (PLP) and to a lesser extent pyridoxamine phosphate (PMP), derived from the parent compounds pyridoxine, pyridoxal, and pyridoxamine. In the bloodstream, PLP is carried to tissues, representing the readily available pool your body can use.
Vitamin B6's active form (PLP) is a coenzyme for many enzymes that handle amino acids—building and reshaping proteins, and creating key brain messengers like serotonin, dopamine, and GABA. It supports making heme for hemoglobin in red blood cells, helps the body convert homocysteine into cysteine (transsulfuration), and assists in releasing glucose from glycogen during energy needs (glycogen phosphorylase). Plasma vitamin B6 therefore reflects the body's immediate supply for protein metabolism, neurotransmitter production, oxygen-carrying capacity, energy mobilization, and aspects of immune function.
Why PLP availability matters across nerve, blood, and vessel biology
Vitamin B6 (measured in plasma, typically as pyridoxal-5-phosphate) is the body's versatile coenzyme for amino-acid processing, neurotransmitter production, heme synthesis, glycogen breakdown, and one-carbon metabolism. This test shows how available B6 is for those reactions across brain, blood, immune, and metabolic systems. It is central to amino acid and protein turnover, neurotransmitter formation (serotonin, dopamine, GABA), hemoglobin synthesis, glucose release from glycogen, and one-carbon metabolism that helps control homocysteine. Adequate PLP supports energy production, cardiovascular integrity, cognition and mood, reproductive health, and immune defense.
Big picture, B6 status connects neurotransmission, red-cell and immune health, glucose handling, and vascular biology. It interlocks with folate and B12 around homocysteine, and it is influenced by inflammation and protein status. Keeping B6 in a healthy range supports long-term neurologic function, hematologic robustness, and cardiovascular resilience.
High and low PLP: what each pattern points to
On most lab reports, values in the middle of the reference range generally reflect adequate tissue status; values near the bottom suggest limited availability, and very high values usually indicate excess. Being in range suggests adequate coenzyme availability for stable protein metabolism, resilient neurochemistry, efficient hemoglobin production, balanced glucose handling, and effective homocysteine control in concert with folate and B12. In the absence of inflammation, values near the mid-portion of a laboratory's reference interval generally indicate robust status.
When the value is low, the body struggles to make serotonin, dopamine, and GABA, and to build heme and antibodies. Low values usually reflect insufficient intake or absorption, increased demand, or redistribution during inflammation. Physiologically, low PLP limits transamination and decarboxylation reactions, leading to reduced neurotransmitter synthesis (mood changes, irritability, seizures in severe deficiency), impaired heme synthesis (microcytic or sideroblastic anemia, fatigue), less efficient glycogenolysis (low-energy symptoms), and higher homocysteine (vascular stress). People may notice irritability, low mood, poor concentration, peripheral tingling or burning, or a seizure tendency in infants. Fatigue can result from microcytic or sideroblastic anemia; skin and mouth changes (seborrheic rash, glossitis, cheilitis) may appear. Homocysteine can rise, adding cardiovascular strain. Pregnancy, inflammatory states, older age, alcohol use, and certain medicines can depress plasma B6; in pregnancy, low B6 is linked to worse nausea and higher homocysteine. Levels tend to run lower in pregnancy and with estrogen-containing contraceptives, in older adults, with chronic inflammation or low albumin, alcohol use, and with certain medications.
When the value is high, it is most often from supplements rather than food. High values usually reflect recent supplementation or high intake, or reduced renal clearance of B6 vitamers. Excess B6—especially pyridoxine—can injure sensory nerves, causing numbness, burning, loss of vibration sense, and unsteady gait, sometimes with photosensitivity or rash. Very high circulating B6—especially pyridoxine forms—can be associated with sensory nerve dysfunction, though plasma PLP does not always track toxicity. Rarely, reduced clearance in liver or kidney disease contributes.
Inflammation, medications, and assay variability
Most labs measure PLP, but some report other B6 forms; assays are light-sensitive and vary by method. Fasting samples reduce postprandial variation. Inflammation and low albumin lower plasma PLP independent of tissue status. Pregnancy lowers circulating PLP. Renal disease alters B6 vitamer patterns. Recent supplementation transiently elevates results.
FAQs
A plasma vitamin B6 test measures the amount of vitamin B6, primarily as pyridoxal 5′-phosphate (PLP), circulating in your blood. This test is important because PLP is the active coenzyme form of vitamin B6, essential for over 100 enzyme reactions in the body. These reactions include amino acid metabolism, neurotransmitter synthesis (serotonin, dopamine, GABA), red blood cell formation, glucose metabolism, and homocysteine regulation. Monitoring plasma B6 helps detect deficiencies or excess, guides supplementation, and supports overall metabolic, neurological, and cardiovascular health.
Vitamin B6 deficiency can lead to a range of symptoms and health issues. Early signs include fatigue, irritability, and skin changes such as seborrheic dermatitis. More severe deficiency may cause peripheral neuropathy (numbness, tingling), anemia due to impaired heme synthesis, glossitis, angular cheilitis, and elevated homocysteine, which increases cardiovascular risk. In infants, deficiency can cause seizures. Groups at higher risk include pregnant individuals, older adults, those with poor dietary intake, chronic inflammation, liver disease, or those taking certain medications.
High plasma vitamin B6 levels are most commonly caused by excessive supplementation or frequent intake of fortified foods. Less commonly, serious illnesses affecting metabolism or clearance, such as kidney or liver dysfunction, can elevate PLP. Sustained high levels may lead to sensory nerve damage (sensory axonal neuropathy), presenting as numbness, burning, or gait imbalance. Unexpectedly high results without supplementation should be interpreted in clinical context, considering possible acute illness or organ dysfunction.
Vitamin B6 works closely with vitamin B12 and folate in the regulation of homocysteine, an amino acid linked to cardiovascular risk. Together, these vitamins support the conversion of homocysteine to methionine or cysteine, helping maintain healthy blood vessels and reduce vascular risk. Deficiency in any of these nutrients can disrupt this pathway, leading to elevated homocysteine. Reviewing B6 status alongside B12 and folate results provides a comprehensive view of one-carbon metabolism and cardiovascular health.
Maintaining within reference range plasma vitamin B6 levels helps support that PLP-dependent enzymes function efficiently. Benefits include steady amino acid and glucose metabolism, balanced neurotransmitter production for mood and cognition, healthy red blood cell and immune function, and effective homocysteine regulation. Adequate B6 supports energy production, cardiovascular health, neurological function, and overall metabolic flexibility. Most people do well with mid-range values; there is no proven benefit to very high levels.
Superpower currently offers at-home blood testing in the following states: Alabama, Arizona, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Idaho, Illinois, Indiana, Kansas, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, and Wisconsin.
We’re actively expanding nationwide, with new states being added regularly. If your state isn’t listed yet, stay tuned.
References
- National Institutes of Health, Office of Dietary Supplements. (2023). Vitamin B6: Fact sheet for health professionals. https://ods.od.nih.gov/factsheets/VitaminB6-HealthProfessional/
- Ueland, P. M., Ulvik, A., Rios-Avila, L., Midttun, O., & Gregory, J. F. (2015). Direct and functional biomarkers of vitamin B6 status. Annual Review of Nutrition, 35, 33-70. https://doi.org/10.1146/annurev-nutr-071714-034330
- Ueland, P. M., McCann, A., Midttun, O., & Ulvik, A. (2017). Inflammation, vitamin B6 and related pathways. Molecular Aspects of Medicine, 53, 10-27. https://doi.org/10.1016/j.mam.2016.08.001
- Sakakeeny, L., Roubenoff, R., Obin, M., Fontes, J. D., Benjamin, E. J., Bujanover, Y., Jacques, P. F., & Selhub, J. (2012). Plasma pyridoxal-5-phosphate is inversely associated with systemic markers of inflammation. The Journal of Nutrition, 142(7), 1280-1285. https://doi.org/10.3945/jn.111.153056
- Wu, X. Y., & Lu, L. (2012). Vitamin B6 deficiency, genome instability and cancer. Asian Pacific Journal of Cancer Prevention, 13(11), 5333-5338. https://doi.org/10.7314/apjcp.2012.13.11.5333






































.avif)
